January 18, 2024
Novel GHz-class NMR systems are enabling unprecedented life science and materials research in functional structural biology, drug discovery, metabolomics and cleantech research. COLUMBUS, Ohio - Bruker Corporation, the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions for life and materials research, today announced the successful installation of a 1.2 Gigahertz (GHz) NMR system at [...]
January 18, 2024
This weekend LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning at the International Plant and Animal Genome conference (PAG) in San Diego. This groundbreaking product rapidly delivers high-purity DNA in high-yields, typically achieving results in 5 minutes – from lysate to eluate – for both plant and animal samples. This magnetic [...]
iXCells Biotechnologies Strengthens Leadership Team; Welcomes New CEO
January 18, 2024
Helge Bastian, PhD, joins executive team as new CEO. SAN DIEGO -- iXCells Biotechnologies USA, Inc. ("iXCells"), a cell technology company specializing in providing cell-based products and drug discovery service solutions to the global academic, biotech, pharmaceutical, and rare disease communities, today announced the appointment of Helge Bastian, PhD, as the company’s new Chief Executive [...]
January 18, 2024
COLUMBIA, Md. — Shimadzu Scientific Instruments introduces the ICPMS-2040/2050 series of inductively coupled plasma mass spectrometers that feature a proprietary advanced mini-torch system, a redesigned collision/reaction cell and a high-performance quadrupole mass filter with enhanced resolution. The ICPMS-2040/2050 series is ideal for analyzing the concentration of inorganic elements in solution samples in a wide range of [...]
GeminiBio Appoints Steven Sandoval, Sr. to its Board of Directors
January 18, 2024
* Senior biopharma and cell therapy engineering/operations executive with 30+ years of experience to help drive growth FORT LAUDERDALE, Fla. and WEST SACRAMENTO, Calif. -- Gemini BioProducts Holding, Inc. ("GeminiBio" or the "Company"), a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Florida-based healthcare private equity firm, announced the appointment of Steven Sandoval, Sr., to its Board of [...]
Correction: Bio-Works receives repeat order worth 2.4 MSEK order for WorkBeads resin
January 18, 2024
The original press release stated that the order value was 1.9 MSEK, but the actual order value is 2.4 MSEK. Bio-Works has received a new order from a production customer in the Netherlands worth 2.4 MSEK. The order is a repeat order for a project to which Bio-Works has previously delivered. The customer is a [...]
The first MerlinEM RDP has been successfully installed
January 18, 2024
Quantum Detectors is proud to announce that the first MerlinEM RDP detector has been successfully installed, at the Centre National de la Recherche Scientifique (CNRS). On 4th December 2023, our dedicated customer support team visited Dr. Martien den Hertog and the team at CNRS in Grenoble, to install the first ever MerlinEM RDP detector. The [...]
January 17, 2024
Today, Eppendorf, a renowned leader in the life science industry announces the launch of the revised Enhanced Feature Set GxP software extension for epMotion automated liquid handlers. The extension is designed to support customers operating in GxP environments and to achieve compliance with critical regulations such as 21 CFR Part 11, EU GMP Annex 11, and GAMP® 5. In regulated industries, [...]
January 17, 2024
Austin, TX – L7 Informatics, the industry leader providing scientific software solutions for research, development, manufacturing, and quality control operations, is excited to announce a strategic partnership with Cellipont Bioservices, a distinguished CDMO specializing in cell therapy manufacturing. This collaboration marks a pivotal moment as Cellipont embraces L7 Informatics’ L7|ESP™ unified platform and its integrated [...]
ERS Genomics and StemSight sign CRISPR/Cas9 license agreement
January 17, 2024
License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in development of cell therapies for corneal blindness Dublin, Ireland, and Tampere, Finland: ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr Emmanuelle Charpentier, and StemSight Oy (‘StemSight’), a biotechnology [...]

